GGrantIndex
← Leaderboards

Luc Van Kaer

Vanderbilt University Medical Center

$12,242,936
Attributed
$12,911,772
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200523
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$12,911,772 · 10

By mechanism

R01$11,345,203 · 7
P01$1,140,214 · 2
R21$426,355 · 1

Top collaborators

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Cytokine

Research focus

CytokineResponseImmune ResponsePhenotypeCellsIn VivoAntigensPlayImmune SystemReceptorCell TypeGlycolipidsImmunotherapyProductionInflammatoryBaseT-LymphocytePathway InteractionsMolecularPreventPublishingImmuneSignal TransductionProteins

Grant awards (38)

Role of autophagy-related protein Vps34 in antigen presentation and self-tolerance$525,370
R01 · FY2023 · AI · contact PI
Role of autophagy-related protein Vps34 in antigen presentation and self-tolerance$525,370
R01 · FY2021 · AI · contact PI
Role of autophagy-related protein Vps34 in antigen presentation and self-tolerance$71,741
R01 · FY2021 · AI · contact PI
Role of autophagy-related protein Vps34 in antigen presentation and self-tolerance$525,370
R01 · FY2020 · AI · contact PI
Role of autophagy-related protein Vps34 in antigen presentation and self-tolerance$69,492
R01 · FY2020 · AI · contact PI
Role of autophagy-related protein Vps34 in antigen presentation and self-tolerance$525,370
R01 · FY2019 · AI · contact PI
iCD8alpha cells as novel innate-type lymphoid cells that mediate gut immunity$315,722
R01 · FY2018 · DK · contact PI
iCD8alpha cells as novel innate-type lymphoid cells that mediate gut immunity$315,722
R01 · FY2017 · DK · contact PI
iCD8alpha cells as novel innate-type lymphoid cells that mediate gut immunity$315,722
R01 · FY2016 · DK · contact PI
iCD8alpha cells as novel innate-type lymphoid cells that mediate gut immunity$313,726
R01 · FY2015 · DK · contact PI
Glycolipid-Reactive NKT Cells, Obesity and Insulin Resistance$309,247
R01 · FY2013 · DK · contact PI
Modulation of chronic vascular inflammation by iNKT cells$379,913
R01 · FY2012 · HL · contact PI
Glycolipid-Reactive NKT Cells, Obesity and Insulin Resistance$320,463
R01 · FY2012 · DK · contact PI
Modulation of chronic vascular inflammation by iNKT cells$383,750
R01 · FY2011 · HL · contact PI
Mechanisms and consequences of iNKT cell anergy$368,968
R01 · FY2011 · AI · contact PI
Glycolipid-Reactive NKT Cells, Obesity and Insulin Resistance$320,463
R01 · FY2011 · DK · contact PI
Glycolipid-Reactive NKT Cells, Obesity and Insulin Resistance$387,500
R01 · FY2010 · DK · contact PI
Modulation of chronic vascular inflammation by iNKT cells$383,750
R01 · FY2010 · HL · contact PI
Mechanisms and consequences of iNKT cell anergy$372,695
R01 · FY2010 · AI · contact PI
Role Of The Thymus Leukemia Antigen In Mucosal Immunity$193,855
R21 · FY2010 · AI · contact PI
Modulation of chronic vascular inflammation by iNKT cells$383,750
R01 · FY2009 · HL · contact PI
Mechanisms and consequences of iNKT cell anergy$376,459
R01 · FY2009 · AI · contact PI
Role Of The Thymus Leukemia Antigen In Mucosal Immunity$232,500
R21 · FY2009 · AI · contact PI
Mechanisms and consequences of iNKT cell anergy$376,459
R01 · FY2008 · AI · contact PI
Mechanisms and consequences of iNKT cell anergy$383,750
R01 · FY2007 · AI · contact PI
Modulation of type I diabetes with NKT cells$368,629
R01 · FY2006 · AI · contact PI
T Lymphocyte based functional genomics of inflammation$301,420
P01 · FY2006 · HL · contact PI
Core--Animal models$301,420
P01 · FY2006 · HL · contact PI
Modulation of type I diabetes with NKT cells$377,500
R01 · FY2005 · AI
Modulation of EAE with ligand-activated NKT cells$322,763
R01 · FY2005 · NS
Modulation of type I diabetes with NKT cells$377,500
R01 · FY2004 · AI
Modulation of EAE with ligand-activated NKT cells$322,763
R01 · FY2004 · NS
Modulation of type I diabetes with NKT cells$377,500
R01 · FY2003 · AI
Modulation of EAE with ligand-activated NKT cells$322,763
R01 · FY2003 · NS
Modulation of EAE with ligand-activated NKT cells$322,763
R01 · FY2002 · NS
Modulation of type I diabetes with NKT cells$302,250
R01 · FY2002 · AI
Core--Animal models$268,687
P01 · FY2002 · HL
T Lymphocyte based functional genomics of inflammation$268,687
P01 · FY2002 · HL